Company Filing History:
Years Active: 2025
Title: Michal Czesław Piotrowicz: Innovator in Therapeutic Applications
Introduction
Michal Czesław Piotrowicz is a notable inventor based in Łódź, Poland. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic applications related to chitinase-like proteins.
Latest Patents
His most recent patent focuses on YKL-40 inhibitors and their therapeutic applications. The patent discloses assays for screening active compounds that interfere with the interaction between chitinase-like protein YKL-40 and chitin oligomers, as well as with heparan sulfate. Additionally, it identifies active compounds as inhibitors of YKL-40, detailing their therapeutic applications and their use in biosensors for measuring YKL-40 levels in biological samples. This patent represents a significant advancement in the understanding and potential treatment of diseases associated with YKL-40.
Career Highlights
Michal Czesław Piotrowicz is currently associated with Molecure S.A., where he continues to innovate and develop new therapeutic solutions. His work has been instrumental in advancing the field of biotechnology, particularly in the context of disease treatment and diagnostics.
Collaborations
He has collaborated with notable colleagues, including Łukasz Krzemiński and Wojciech J Czestkowski, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Michal Czesław Piotrowicz's contributions to the field of biotechnology, particularly through his patent on YKL-40 inhibitors, highlight his role as a key innovator in therapeutic applications. His ongoing work at Molecure S.A. continues to pave the way for advancements in medical science.